Cite
Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scand J Immunol. 2022;95(2):e13131doi: 10.1111/sji.13131.
Pourgholaminejad, A., Pahlavanneshan, S., & Basiri, M. (2022). COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scandinavian journal of immunology, 95(2), e13131. https://doi.org/10.1111/sji.13131
Pourgholaminejad, Arash, et al. "COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges." Scandinavian journal of immunology vol. 95,2 (2022): e13131. doi: https://doi.org/10.1111/sji.13131
Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scand J Immunol. 2022 Feb;95(2):e13131. doi: 10.1111/sji.13131. Epub 2022 Jan 03. PMID: 34936112.
Copy
Download .nbib